Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.71
Price to sales ratio
2 643.82

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1444
ICUI
ICU Medical, Inc. - Common Stock
175.10 USD0.00%-4.89%+4.40%+41.56%4.38 B USD
1450
NVST
Envista Holdings Corporation Common Stock
27.14 USD-1.09%-3.11%-3.07%+31.62%4.36 B USD
1701
WRBY
Warby Parker Inc. Class A Common Stock
25.00 USD-1.11%-8.76%-5.23%-2.42%3.09 B USD
1863
ATRC
AtriCure, Inc. - Common Stock
48.54 USD-1.48%-0.84%+19.12%+27.97%2.47 B USD

Frequently asked questions about Pulse Biosciences, Inc Common Stock (DE)

What is the Pulse Biosciences, Inc Common Stock (DE) stock price today?

The current price of Pulse Biosciences, Inc Common Stock (DE) (PLSE) is 47.57. Over the past 24 hours, the stock has changed by -2.04%. Follow the PLSE chart for real-time price dynamics.

What is the stock ticker of Pulse Biosciences, Inc Common Stock (DE)?

Pulse Biosciences, Inc Common Stock (DE) trades under the ticker PLSE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Pulse Biosciences, Inc Common Stock (DE) stock going up?

PLSE has changed by -4.88% over the last week, +39.50% over the last month, and +162.09% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Pulse Biosciences, Inc Common Stock (DE)?

Pulse Biosciences, Inc Common Stock (DE) currently has a market capitalization of 3.39 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Pulse Biosciences, Inc Common Stock (DE) earnings last quarter?

Last quarter, Pulse Biosciences, Inc Common Stock (DE) reported earnings of -0.36 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Pulse Biosciences, Inc Common Stock (DE) revenue for the last quarter?

Pulse Biosciences, Inc Common Stock (DE) reported quarterly revenue of 434 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Pulse Biosciences, Inc Common Stock (DE) net income for the last quarter?

Pulse Biosciences, Inc Common Stock (DE) reported net income of -24.66 M for the last quarter. The previous quarter showed -18.58 M, which means net income changed by -32.70%.

How many employees does Pulse Biosciences, Inc Common Stock (DE) have?

As of the latest available data, Pulse Biosciences, Inc Common Stock (DE) has 116 employees. Workforce size can provide additional context about the company's scale and operations.

What is Pulse Biosciences, Inc Common Stock (DE) EBITDA?

Pulse Biosciences, Inc Common Stock (DE) EBITDA is -24.85 M, and its EBITDA margin is -5 726.04%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Pulse Biosciences, Inc Common Stock (DE) stock?

You can buy Pulse Biosciences, Inc Common Stock (DE) (PLSE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Pulse Biosciences, Inc Common Stock (DE) stock?

Investing in Pulse Biosciences, Inc Common Stock (DE) requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PLSE chart and related analysis on metatrader.com as part of your research.

News